
Trace the evolution from the MDD to the MDR, the shift from directive to regulation, and the critical timelines for legacy devices and post-market surveillance.
Explore how the MDR expands scope under Article 2 to include medical devices, aesthetic products, and software, with Annex 16 and accessories regulated for diagnosing, monitoring, and treatment.
The MDR builds a supply chain of trust from manufacturer to EC-Rep, importer, and distributor, who perform four-step checks, CE marking, declaration of conformity, labeling, storage, and share safety responsibility.
Explore how the MDR uses a risk-based pyramid from class 1 to 3, applies Annex 8 rules, including rule 11 for software, and maps conformity routes for the CE mark.
Learn how the MDR's General Safety and Performance Requirements (GSPRs), expanded from MDD, guide risk management, design, and information supplied to demonstrate compliance.
Explore MDR conformity routes, where notified bodies audit your QMS and technical files to grant the CE certificate. Audits intensify by risk class, guided by ISO 13485 and GSPRs.
Explain how to prove device safety with clinical data via the clinical evaluation report and robust documentation, including UDI traceability, NX2, and PMCF under MDR.
Learn the MDR's technical documentation structure, detailing Annex 2 and Annex 3 requirements, the up-to-date technical file, and integrated risk management for audits.
Labeling and UDI under the MDR enable full traceability and safety by requiring manufacturer details, intended use, warnings, and lot or serial numbers, with device and production identifiers on packaging.
Learn to implement postmarket surveillance under the MDR by gathering data through surveys, patient registries, and user feedback, and update risk management and clinical evaluation with PSURs and PMS reports.
Explore vigilance and incident reporting under the MDR, including defining serious incidents and the two-day, ten-day, and fifteen-day deadlines. Apply FSCA, FSN notices, and trend reporting to monitor device risks.
Understand Udamed, the EU data hub for medical devices, linking six modules and enabling public transparency through SRNs and SSCPs across vigilance, PMS, and market surveillance.
“This course contains the use of artificial intelligence.”
The European medical device landscape has undergone its most significant legislative overhaul in decades. The transition from the Medical Device Directive (MDD) to the Medical Device Regulation (MDR 2017/745) is not merely an update; it is a fundamental shift in legal enforcement that demands immediate strategic attention from manufacturers, importers, and distributors globally.
Medical Device Regulations (MDR) Essentials is a professional-grade training program designed to demystify the complex requirements of the new EU framework. This course moves beyond theoretical legal text to provide actionable compliance strategies for maintaining market access in the European Union.
This course is structured to guide professionals through the entire regulatory lifecycle of a medical device. We begin by establishing the legal ground, examining the strict transition timelines and the new "Supply Chain of Trust" liabilities for economic operators. Participants will then navigate the rigorous risk-based classification system (Annex VIII), specifically addressing the up-classification of software (SaMD) and the inclusion of aesthetic products under Annex XVI.
A core focus of this curriculum is the "Proactive Surveillance" paradigm shift. You will learn how to transition from reactive vigilance to proactive Post-Market Surveillance (PMS), ensuring your Technical Documentation (Annex II & III) and Clinical Evaluation Reports (CER) are "living" documents that satisfy Notified Body audits.
Key areas of focus include:
Strategic Transition: Navigating legacy device provisions and the expiration of MDD certificates.
Technical Compliance: Exploring the General Safety and Performance Requirements (GSPRs) that replace the old Essential Requirements.
Clinical Evidence: Understanding strict equivalence rules and the lifecycle approach to Clinical Evaluation (CER) and Post-Market Clinical Follow-up (PMCF).
Transparency & Traceability: Implementing Unique Device Identification (UDI) and understanding EUDAMED.
Designed for regulatory affairs professionals, quality managers, and life sciences executives, this course offers a structured path to understanding the rigorous safety standards required to place—and keep—medical devices on the EU market in 2025 and beyond.